1. Home
  2. AKRO vs OGS Comparison

AKRO vs OGS Comparison

Compare AKRO & OGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • OGS
  • Stock Information
  • Founded
  • AKRO 2017
  • OGS 1906
  • Country
  • AKRO United States
  • OGS United States
  • Employees
  • AKRO N/A
  • OGS N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • OGS Oil/Gas Transmission
  • Sector
  • AKRO Health Care
  • OGS Utilities
  • Exchange
  • AKRO Nasdaq
  • OGS Nasdaq
  • Market Cap
  • AKRO 3.9B
  • OGS 4.3B
  • IPO Year
  • AKRO 2019
  • OGS N/A
  • Fundamental
  • Price
  • AKRO $50.09
  • OGS $76.27
  • Analyst Decision
  • AKRO Strong Buy
  • OGS Buy
  • Analyst Count
  • AKRO 7
  • OGS 6
  • Target Price
  • AKRO $81.57
  • OGS $77.75
  • AVG Volume (30 Days)
  • AKRO 997.3K
  • OGS 441.4K
  • Earning Date
  • AKRO 08-08-2025
  • OGS 08-05-2025
  • Dividend Yield
  • AKRO N/A
  • OGS 3.50%
  • EPS Growth
  • AKRO N/A
  • OGS 6.57
  • EPS
  • AKRO N/A
  • OGS 4.21
  • Revenue
  • AKRO N/A
  • OGS $2,330,032,000.00
  • Revenue This Year
  • AKRO N/A
  • OGS $23.73
  • Revenue Next Year
  • AKRO N/A
  • OGS $4.03
  • P/E Ratio
  • AKRO N/A
  • OGS $18.15
  • Revenue Growth
  • AKRO N/A
  • OGS 13.43
  • 52 Week Low
  • AKRO $21.34
  • OGS $66.32
  • 52 Week High
  • AKRO $58.40
  • OGS $82.25
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 49.73
  • OGS 65.03
  • Support Level
  • AKRO $47.10
  • OGS $74.44
  • Resistance Level
  • AKRO $53.02
  • OGS $76.72
  • Average True Range (ATR)
  • AKRO 2.14
  • OGS 1.13
  • MACD
  • AKRO -0.01
  • OGS 0.37
  • Stochastic Oscillator
  • AKRO 51.97
  • OGS 91.00

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About OGS ONE Gas Inc.

ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.

Share on Social Networks: